Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06864338 · ClinicalTrials.gov registry record

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

A clinical trial of Colorectal Cancer Screening and Colorectal Cancer Metastatic, sponsored by Mainz Biomed.

Recruiting
Registry status
2,700
Enrollment target
1
Study location

NCT06864338 is a study of Colorectal Cancer Screening and Colorectal Cancer Metastatic that is actively recruiting participants, run by Mainz Biomed. The registered enrollment target is 2,700 participants, below the 5,741-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06864338, a study of Colorectal Cancer Screening and Colorectal Cancer Metastatic, is actively recruiting participants, sponsored by Mainz Biomed.

RECRUITING
Registry status
2,700 participants
Enrollment target
1
Study location

Study Summary

The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.

Study Locations (1)

North Carolina

  • Virtual Research Group - Morrisville

Trial Details

FieldValue
Enrollment Target 2,700 participants
Start Date 2022-12-18
Est. Completion 2025-11-30

Sponsor

Mainz Biomed

1 total trials

What the Registry Record Tells You About NCT06864338

The ClinicalTrials.gov registry entry for NCT06864338 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,741-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (53% lower). The listed sponsor is Mainz Biomed, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 0 interventions.

NCT06864338 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06864338 about?

NCT06864338 is a clinical study titled "Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test". The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.

What is the current status of trial NCT06864338?

This trial is currently recruiting. The enrollment target is 2,700 participants. The study started on 2022-12-18. Estimated completion is 2025-11-30.

What conditions does trial NCT06864338 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening, Colorectal Cancer Metastatic, Colon Adenocarcinoma.

Who is sponsoring clinical trial NCT06864338?

This trial is sponsored by Mainz Biomed, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06864338 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.